Log in to save to my catalogue

Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin

Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4a8cb6635b9d4fb98e9074b6bcb3b50f

Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Inhibition of Janus kinase (JAK) family enzymes is a popular strategy for treating inflammatory and autoimmune skin diseases. In the clinic, small molecule JAK inhibitors show distinct efficacy and safety profiles, likely reflecting variable selectivity for JAK subtypes. Absolute JAK subtype selectivity has not yet been achieved. Here, we rationall...

Alternative Titles

Full title

Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4a8cb6635b9d4fb98e9074b6bcb3b50f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4a8cb6635b9d4fb98e9074b6bcb3b50f

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-42714-4

How to access this item